Back

Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020

Mizumoto, K.; Chowell, G.

2020-02-23 infectious diseases
10.1101/2020.02.19.20025163 medRxiv
Show abstract

Since the first case of Novel Coronavirus (2019-nCov) was identified in December 2019 in Wuhan City, China, the number of cases continues to grow across China and multiple cases have been exported to other countries. The cumulative number of reported deaths is at 637 as of February 7, 2020. Here we statistically estimated the time-delay adjusted death risk for Wuhan as well as for China excluding Wuhan to interpret the current severity of the epidemic in China. We found that the latest estimates of the death risk in Wuhan could be as high as 20% in the epicenter of the epidemic whereas we estimate it [~]1% in the relatively mildly-affected areas. Because the elevated death risk estimates are likely associated with a breakdown of the medical/health system, enhanced public health interventions including social distancing and movement restrictions should be effectively implemented to bring the epidemic under control.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
International Journal of Infectious Diseases
126 papers in training set
Top 0.1%
22.3%
2
Virologica Sinica
10 papers in training set
Top 0.1%
6.3%
3
Clinical Infectious Diseases
231 papers in training set
Top 1%
3.9%
4
The Innovation
12 papers in training set
Top 0.1%
3.6%
5
Eurosurveillance
80 papers in training set
Top 0.3%
3.6%
6
Journal of Medical Virology
137 papers in training set
Top 1.0%
3.6%
7
Scientific Reports
3102 papers in training set
Top 42%
3.0%
8
Journal of Clinical Medicine
91 papers in training set
Top 2%
2.6%
9
Cell Discovery
54 papers in training set
Top 2%
2.6%
50% of probability mass above
10
Emerging Microbes & Infections
74 papers in training set
Top 0.5%
2.3%
11
Frontiers in Medicine
113 papers in training set
Top 3%
2.1%
12
PLOS ONE
4510 papers in training set
Top 48%
2.1%
13
Science China Life Sciences
26 papers in training set
Top 0.7%
2.1%
14
Journal of Infection
71 papers in training set
Top 1%
1.9%
15
Frontiers in Genetics
197 papers in training set
Top 5%
1.7%
16
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.7%
1.7%
17
Frontiers in Public Health
140 papers in training set
Top 5%
1.6%
18
Cellular & Molecular Immunology
14 papers in training set
Top 1%
1.5%
19
Journal of Molecular Cell Biology
21 papers in training set
Top 0.3%
1.5%
20
The Lancet Infectious Diseases
71 papers in training set
Top 2%
1.3%
21
Infectious Diseases of Poverty
10 papers in training set
Top 0.2%
1.2%
22
eLife
5422 papers in training set
Top 49%
1.2%
23
JMIR Public Health and Surveillance
45 papers in training set
Top 3%
1.2%
24
Nature Communications
4913 papers in training set
Top 58%
0.9%
25
Science of The Total Environment
179 papers in training set
Top 4%
0.9%
26
Frontiers in Physics
20 papers in training set
Top 0.7%
0.9%
27
BioMed Research International
25 papers in training set
Top 3%
0.9%
28
Emerging Infectious Diseases
103 papers in training set
Top 2%
0.9%
29
Epidemiology and Infection
84 papers in training set
Top 3%
0.8%
30
PeerJ
261 papers in training set
Top 14%
0.8%